ClinicalTrials.Veeva

Menu

Ultrasound Staging in the Placenta Accreta

B

Beni-Suef University

Status

Completed

Conditions

Staging of Placental Invasion
Obstetric Labor Complications

Treatments

Device: Ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT04253197
Beni-Suef 3-2017

Details and patient eligibility

About

The investigators evaluated the efficacy of a staging system introduced by the American Institute of ultrasound in medicine 2015 including sonographic parameters associated with morbidly adherent placenta for antenatal prediction of placental invasion.

Full description

Morbidly adherent placenta (MAP) defines a spectrum of conditions, including placenta accreta, increta, and percreta, which are associated with significant maternal and fetal morbidity and mortality. Ultrasound evaluation, with grayscale, is the recommended first-line modality for diagnosing MAP. Grayscale ultrasound features suggestive of placenta accreta include the loss of myometrial interface or retroplacental clear space, reduced myometrial thickness and the presence of intraplacental lacunae. Using a staging system by antenatal ultrasound can predict placental invasion antenatally.

Enrollment

75 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Prior lower segment cesarean section
  • Low lying anterior placenta
  • Singleton pregnancy

Exclusion criteria

  • Medical disorders
  • vasa previa

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

Morbidly adherent placenta
Other group
Description:
This arm was given stage according to ultrasound features.
Treatment:
Device: Ultrasound

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems